AGIO
Agios Pharmaceuticals
$38.12
+$0.09 (+0.24%)Oct 28, 2026
Key metrics
The numbers that frame AGIO today
- Market cap
- $2.28B
- Gross margin
- 92%
- EV / Sales
- 22.4
- ROIC
- -37.1%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $22.24
- 52wk High
- $46.00
Growth
Revenue and earnings trend for AGIO
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about AGIO
Is Agios Pharmaceuticals a good buy?
Hold. Agios Pharmaceuticals has strong momentum, but weak quality makes the setup mixed. Growth looks strong, which supports the long-term business case, but quality and momentum do not clear the bar together. We think Agios Pharmaceuticals is selling at a very high price.
What is the market capitalization of AGIO?
Agios Pharmaceuticals's market capitalization is $2.28B.
What is the 52-week high for AGIO stock?
The 52-week high for Agios Pharmaceuticals is $46.00. The current close of $38.12 is 17.1% below that high.
What is the 52-week low for AGIO stock?
The 52-week low for Agios Pharmaceuticals is $22.24. The current close of $38.12 is 71.4% above that low.
Does AGIO stock pay dividends?
Agios Pharmaceuticals does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for AGIO?
Agios Pharmaceuticals's Debt / Equity ratio is 0.03.